Overexpressed recombinant quorum quenching lactonase reduces the virulence, motility and biofilm formation of multidrug-resistant Pseudomonas aeruginosa clinical isolates
Sakr, Masarra M; Aboshanab K. M.; Elkhatib, Walid F; Yassien, Mahmoud A; Hassouna, Nadia A;
Abstract
The increasing occurrence of resistance among Pseudomonas aeruginosa clinical isolates necessitates finding alternatives to antibiotics for controlling the infection of such pathogenic bacteria. In this study, lactonase gene ahl-1 from Bacillus weihenstephanensis isolate-P65 was successfully cloned and expressed in Escherichia coli BL21 (DE3) under the control of T7 promoter for utilizing its quorum quenching activity against three multidrug-resistant (MDR) P. aeruginosa clinical isolates. The biological activity of the overexpressed lactonase enzyme (Ahl-1), tested using a synthetic signal and Chromobacterium violaceum CV026 as a biosensor, displayed good catalytic activity using hexanoyl homoserine lactone (HHL) as a substrate and Chromobacterium violaceum (CV026) as a biosensor (77.2 and 133 nm min-1 for the crude and the purified Ahl-lactonase enzymes, respectively). Upon challenging its ability to inhibit the virulence of three MDR P. aeruginosa clinical isolates, recombinant Ahl-1 successfully prevented the accumulation of acylhomoserine lactone signals resulting in a significant reduction in the investigated virulence determinants; protease (from 40 up to 75.5%), pyocyanin (48-75.9%), and rhamnolipids (52.7-63.4%) (P value < 0.05). Ahl-1 also displayed significant inhibitory activities on the swarming motility and biofilm formation of the three tested MDR P. aeruginosa clinical isolates (P value < 0.05). Consequently, Ahl-1 lactonase enzyme in this study is considered a promising therapeutic agent to inhibit P. aeruginosa pathogenicity with no fear of emergence of resistance.
Other data
Title | Overexpressed recombinant quorum quenching lactonase reduces the virulence, motility and biofilm formation of multidrug-resistant Pseudomonas aeruginosa clinical isolates | Authors | Sakr, Masarra M ; Aboshanab K. M. ; Elkhatib, Walid F ; Yassien, Mahmoud A ; Hassouna, Nadia A | Issue Date | Dec-2018 | Publisher | SPRINGER | Journal | Applied microbiology and biotechnology | DOI | 10613-10622 1432-0614 24 10622 https://api.elsevier.com/content/abstract/scopus_id/85055247761 102 10.1007/s00253-018-9418-2 |
PubMed ID | 30310963 | Scopus ID | 2-s2.0-85055247761 | Web of science ID | WOS:000451523800022 |
Attached Files
File | Description | Size | Format | Existing users please Login |
---|---|---|---|---|
Massara AMAB.pdf | 906.63 kB | Adobe PDF | Request a copy |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.